- Home
- MNKD
MNKD
MannKind Corporation
as of 12-11-2025 2:43pm EST
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | DANBURY |
| Market Cap: | 1.7B | IPO Year: | 2004 |
| Target Price: | $10.08 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.10 | EPS Growth: | 23.47 |
| 52 Week Low/High: | $3.38 - $7.07 | Next Earning Date: | 11-05-2025 |
| Revenue: | $313,787,000 | Revenue Growth: | 17.43% |
| Revenue Growth (this year): | 21.54% | Revenue Growth (next year): | 22.21% |
AI-Powered MNKD Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of MannKind Corporation (MNKD)
Chief Executive Officer
Avg Cost/Share
$5.57
Shares
107,920
Total Value
$601,114.40
Owned After
2,504,792
SEC Form 4
EVP Genl Counsel & Secretary
Avg Cost/Share
$5.57
Shares
147,780
Total Value
$823,134.60
Owned After
841,719
SEC Form 4
EVP Technical Operations
Avg Cost/Share
$5.03
Shares
18,777
Total Value
$94,448.31
Owned After
455,211
SEC Form 4
Chief People & Workpl Officer
Avg Cost/Share
$5.34
Shares
47,000
Total Value
$250,980.00
Owned After
1,032,013
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Castagna Michael | MNKD | Chief Executive Officer | Dec 2, 2025 | Sell | $5.57 | 107,920 | $601,114.40 | 2,504,792 | |
| Thomson David | MNKD | EVP Genl Counsel & Secretary | Dec 2, 2025 | Sell | $5.57 | 147,780 | $823,134.60 | 841,719 | |
| Singh Sanjay R | MNKD | EVP Technical Operations | Nov 14, 2025 | Sell | $5.03 | 18,777 | $94,448.31 | 455,211 | |
| Tross Stuart A | MNKD | Chief People & Workpl Officer | Sep 16, 2025 | Sell | $5.34 | 47,000 | $250,980.00 | 1,032,013 |
Compare MNKD vs Leading Stocks
See how MNKD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MNKD MannKind Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.